|
Q2 FY2027
As of Oct 2, 2026
|
Q1 FY2027
As of Jul 3, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 26, 2025
|
Q1 FY2026
As of Jun 27, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 27, 2024
|
Q1 FY2025
As of Jun 28, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 29, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Accounts receivable, net of allowance of $2,273 and $2,078, respectively | ||||||||||||||||
| Total accounts receivable, net of allowance of $2,273 and $2,078, respectively | ||||||||||||||||
| Contract assets | ||||||||||||||||
| Inventories | ||||||||||||||||
| Section 45X credit receivable | ||||||||||||||||
| Other current assets | ||||||||||||||||
| Nonrelated Party | ||||||||||||||||
| Total other current assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Other intangible assets, net | ||||||||||||||||
| Deferred tax assets and other assets | ||||||||||||||||
| Deferred tax assets | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||
| Deferred revenue | ||||||||||||||||
| Other current liabilities | ||||||||||||||||
| Related Party | ||||||||||||||||
| Nonrelated Party | ||||||||||||||||
| Total other current liabilities | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||
| Tax receivable agreement (TRA) liability | ||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Redeemable non-controlling interests | ||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||
| Common stock, $0.0001 par value, 900,000,000 shares authorized, 150,712,535 shares and 149,391,483 shares issued and outstanding, respectively | ||||||||||||||||
| Common Class A | ||||||||||||||||
| Common Class B | ||||||||||||||||
| Total common stock, $0.0001 par value, 900,000,000 shares authorized, 150,712,535 shares and 149,391,483 shares issued and outstanding, respectively | ||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||
| Non-controlling interest | ||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||
Loading...